Sam Hancock

Sam Hancock

M.Sci. Genetics

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Articles from Sam

How SARS-CoV-2 spike binds to multiple host receptors

How SARS-CoV-2 spike binds to multiple host receptors

Antibody kinetics in recovered COVID-19 patients

Antibody kinetics in recovered COVID-19 patients

Researchers to investigate suicidal behavior and self-harm among healthcare workers

Researchers to investigate suicidal behavior and self-harm among healthcare workers

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

SARS-CoV-2 antibody models describe differences between the kinetics of different antibodies

SARS-CoV-2 antibody models describe differences between the kinetics of different antibodies

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.